Comparison of the effect of triple standard treatment of helicobacter pylori versus combination therapy of triple standard treatment with probiotic (Femilact) on treatment of patients with helicobacter pylori infectio
Phase 2
- Conditions
- Helicobacter pylori infection.Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters
- Registration Number
- IRCT201612319014N140
- Lead Sponsor
- Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 142
Inclusion Criteria
affected with helicobacter pylori infection; age of 18 to 75 years.
Exclusion criteria: Stomach cancer; renal or liver failure; pregnancy or breastfeeding; history of stomach surgery; history of treatment failure of helicobacter pylori infection
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Microbial load. Timepoint: 8 weeks after treatment. Method of measurement: through respiratory urease test.
- Secondary Outcome Measures
Name Time Method Probable side effects. Timepoint: 8 weeks after treatment. Method of measurement: through question and physical examination.